Health Catalyst, Inc. — Director's Dealing 2019

Jul 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-29

Reporting Person: HAQUE PROMOD (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-29	Common Stock	C	2952091	—	Acquired	2952091	Indirect
2019-07-29	Common Stock	C	2952090	—	Acquired	2952090	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-29	Series B Convertible Preferred Stock	$	C	1442727	Disposed		Common Stock (1442727)	Indirect
2019-07-29	Series C Convertible Preferred Stock	$	C	577045	Disposed		Common Stock (577045)	Indirect
2019-07-29	Series D Convertible Preferred Stock	$	C	471832	Disposed		Common Stock (471832)	Indirect
2019-07-29	Series E Convertible Preferred Stock	$	C	424568	Disposed		Common Stock (424568)	Indirect
2019-07-29	Series F Convertible Preferred Stock	$	C	35919	Disposed		Common Stock (35919)	Indirect
2019-07-29	Series B Convertible Preferred Stock	$	C	1442727	Disposed		Common Stock (1442727)	Indirect
2019-07-29	Series C Convertible Preferred Stock	$	C	577045	Disposed		Common Stock (577045)	Indirect
2019-07-29	Series D Convertible Preferred Stock	$	C	471831	Disposed		Common Stock (471831)	Indirect
2019-07-29	Series E Convertible Preferred Stock	$	C	424568	Disposed		Common Stock (424568)	Indirect
2019-07-29	Series F Convertible Preferred Stock	$	C	35919	Disposed		Common Stock (35919)	Indirect

Footnotes

F1: The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F2: The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F3: The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F4: The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F5: The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F6: The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.

F7: The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.